Synergistic Analysis of Protein Corona and Haemoglobin Levels Detects Pancreatic Cancer.

ABSTRACT: Simultaneous detection of multiple analytes from a single biological sample is gaining more attention in the development of more reliable and point-of-care diagnostic devices. We developed a multiplexed strategy that combined outcomes of clinical biomarkers with analysis of the protein corona that forms around graphene oxide sheets upon exposure to patient's plasma. As a paradigmatic case study, we selected pancreatic ductal adenocarcinoma (PDAC), mainly because of the absence of effective detection strategies that resulted in an extremely low five-year survival rate after diagnosis (<10%). Association of protein corona analysis and haemoglobin levels discriminated PDAC patients from healthy volunteers in up to 90% of cases. If further confirmed in larger-cohort studies, this approach may

SUBMITTER: Caputo D 

PROVIDER: S-EPMC7796289 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature